Skip to content

Design, synthesis, and cytotoxic activity evaluation of 1,2,4-Triazole-based Ethanone and Ferrocenylchalcone derivatives: A comparative study.

Sep 2026 · Bioorganic chemistry (Print) · Vol 183, pp. 110567 · 0 citations · 46 references
Medicine

TL;DR

The TA derivatives demonstrated a more favorable balance between antiproliferative potency, tumor selectivity, and effects on wound-closure than the corresponding TAFe complexes, although selected TAFe derivatives exhibited cell line-dependent selectivity.

Abstract

This study aimed to synthesize novel 3,5-disubstituted-1,2,4-triazolyl ethanone (TA) and ferrocenylchalcone derivatives (TAFe) and to evaluate their cytotoxic activities. In this context, 1,2,4-triazole ethanone derivatives (TA) were obtained from the reaction of 3,5-disubstituted-1,2,4-triazole derivatives with phenacyl bromides. These compounds were then converted into 1,2,4-triazole-based ferrocenylchalcone derivatives (TAFe) via Claisen-Schmidt condensation with ferrocenecarboxaldehyde. The cytotoxic potential of the resulting compounds was subsequently evaluated using various biological assays. The biological activities of TA and TAFe compounds were comprehensively evaluated using MTT, LDH, wound-healing, and DNA degradation assays across lung and breast cell lines. In MTT assays, both TA and TAFe series exhibited potent antiproliferative activity in the low-micromolar range (GI50 ≈ 2.2-26.3 μM in lung cancer cells and ≈1.9-12.7 μM in breast cancer cells). Breast cancer cell lines, particularly MDA-MB-231, were generally more sensitive than lung cancer models. Tumor selectivity analysis based on GI50 values revealed distinct biological profiles. Several compounds exhibited pronounced GI50-based selectivity, indicating preferential inhibition of cancer cell proliferation relative to the corresponding normal cells. TA8 displayed a favorable profile, combining low-micromolar antiproliferative activity with GI50-based selectivity, particularly against MDA-MB-231 cells. LDH assays demonstrated low membrane toxicity for both compound series (≈3-7% in lung and up to ≈19% in breast cell models). In the wound-healing assay, both TA and TAFe derivatives exhibited pronounced, cell line-dependent reductions in wound-closure. Selected compounds from both series effectively reduced wound-closure under the experimental conditions, although the magnitude of inhibition varied among cell lines. DNA fragmentation analysis further supported these findings, revealing more pronounced apoptosis-associated DNA fragmentation following TA treatment than with the corresponding TAFe derivatives. Overall, the TA derivatives demonstrated a more favorable balance between antiproliferative potency, tumor selectivity, and effects on wound-closure than the corresponding TAFe complexes, although selected TAFe derivatives exhibited cell line-dependent selectivity. These findings support TA8 as a candidate for further investigation and highlight the 1,2,4-triazole scaffold as a valuable platform for the development of novel anticancer agents.

View source

Similar papers

Open access Aug 2026

DESIGN, SYNTHESIS, AND PRELIMINARY ANTIPROLIFERATIVE EVALUATION OF BENZIMIDAZOLE-1,3,4-OXADIAZOLE HYBRIDS SHOWING PREFERENTIAL ACTIVITY IN BREAST CANCER CELL LINES

Findings indicate that the benzimidazole-1,3,4-oxadiazole hybrid scaffold may provide a useful starting point for the development of breast cancer-oriented antiproliferative candidates.

Mahmut Gozelle, Şevval Yaman, Züleyha Arslan et al. · 0 citations
Sep 2026

Synthesis, anticancer, and antioxidant activity study of some new 3-(4,6-dihydroxypyrimidin-2-yl) -2-(aryl)thiazolidin-4-ones

This study aims to synthesize a series of pyrimidine derivatives linked to active units and evaluate their anticancer and antioxidant activities. First, several Schiff bases were synthesized by the condensation of 2-aminopyrimidine- 4,6-diol with suitable aromatic aldehydes. Subsequently, Schiff bases were subjected to...

Q. A. Jaber · 0 citations
Open access 2026

SYNTHESIS, ANTIMICROBIAL EVALUATION, MOLECULARDOCKING, AND TOXICITY PREDICTIONOFN-BENZYLIDENE-1,2,4-TRIAZOLO[4,3-b]PYRIDAZINEDERIVATIVES

The comprehensive results based on the experimental and computational approaches revealed that these novel hybrids (5a-5k) represent promising scaffolds for the development of antimicrobial and other useful therapeutic drugs, thereby contributing to United Nations Sustainable Development Goal 3: Good Health and Well-be...

N. Devika, M. Mariyappan, J. S. Ruso et al. · 0 citations
Open access Sep 2026

Design, synthesis, in silico studies, and biological evaluation of tosyl-substituted thiazoles, thiazolidin-4-ones, and chromenes as potential anticancer agents

This study provides integrated experimental and computational insights into the anticancer potential of tosylate-bearing heterocyclic scaffolds, addressing gaps in understanding their structure–activity relationships.

Gehad E. Said, Sonia Samy, E. Abdel-Galil et al. · 0 citations
Open access Sep 2026

Design, Synthesis, Characterization, and Anti-Breast Cancer Activity of Novel Pyrazole-Based Chalcones: Insights from Molecular Docking and DFT Studies

A novel series of 1-(furan-3-yl)-3-(1,3-diphenyl-1H-pyrazol-4-yl)prop-2-en-1-one was designed, synthesized, and characterized with the aim of developing potential anti-breast cancer agents. The synthesis was carried out by a Claisen-Schmidt condensation of 1,3-diphenyl-1H-pyrazole-4-carbaldehyde with 2-acetylfuran in t...

Ameen Ali Baig, P. Chavan, N. D. Satyanarayan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.